Brain Tumors Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Tumors, including details on symptoms, benign and malignant tumors, gliomas, screening, treatment.

Volume 6 (2009), Issue 4 (April)

1. Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo.
   Br J Cancer, 100(7): 1154-64. [Abstract] [Full-text]
2. Patched1 deletion increases N-Myc protein stability as a mechanism of medulloblastoma initiation and progression.
   Oncogene, 28(13): 1605-15. [Abstract] [Full-text]
3. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas.
   Am J Pathol, 174(4): 1149-53. [Abstract] [Full-text]
4. Glioma stem cells: not all created equal.
   Cancer Cell, 15(4): 247-9. [Abstract] [Full-text]
5. Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience.
   Neurology, 72(14): 1217-22. [Abstract] [Full-text]
6. Caveolin 1 expression independently predicts shorter survival in oligodendrogliomas.
   J Neuropathol Exp Neurol, 68(4): 425-31. [Abstract] [Full-text]
7. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha.
   Science, 324(5924): 261-5. [Abstract] [Full-text]
8. Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas.
   J Clin Oncol, 27(11): 1884-92. [Abstract] [Full-text]
9. Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98.
   J Clin Oncol, 27(11): 1879-83. [Abstract] [Full-text]
10. Cytokine and growth factor responses after radiotherapy for localized ependymoma.
    Int J Radiat Oncol Biol Phys, 74(1): 159-67. [Abstract] [Full-text]
11. Cross-platform Q-TOF validation of global exo-metabolomic analysis: application to human glioblastoma cells treated with the standard PI 3-Kinase inhibitor LY294002.
    J Chromatogr B Analyt Technol Biomed Life Sci, 877(13): 1352-8. [Abstract] [Full-text]
12. Maximally safe resection followed by hypofractionated re-irradiation for locally recurrent ependymoma in children.
    Pediatr Blood Cancer, 52(7): 804-7. [Abstract] [Full-text]
13. Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation?
    Pediatr Blood Cancer, 52(7): 796-803. [Abstract] [Full-text]
14. Predicting behavioral problems in craniopharyngioma survivors after conformal radiation therapy.
    Pediatr Blood Cancer, 52(7): 860-4. [Abstract] [Full-text]
15. Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan.
    Pediatr Blood Cancer, 52(7): 791-5. [Abstract] [Full-text]
16. Obesity and metabolic changes are common in young childhood brain tumor survivors.
    Pediatr Blood Cancer, 52(7): 853-9. [Abstract] [Full-text]
17. Immunohistochemical and proteomic profile of melanotic medulloblastoma.
    Pediatr Blood Cancer, 52(7): 875-7. [Abstract] [Full-text]
18. Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91.
    Eur J Cancer, 45(7): 1209-17. [Abstract] [Full-text]
19. Down-regulation of K-ras and H-ras in human brain gliomas.
    Eur J Cancer, 45(7): 1294-303. [Abstract] [Full-text]
20. An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET).
    Br J Cancer, 100(8): 1292-302. [Abstract] [Full-text]
21. Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution.
    Oncogene, 28(15): 1807-11. [Abstract] [Full-text]
22. EphrinA5 acts as a tumor suppressor in glioma by negative regulation of epidermal growth factor receptor.
    Oncogene, 28(15): 1759-68. [Abstract] [Full-text]
23. Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study.
    J Clin Oncol, 27(12): 2052-8. [Abstract] [Full-text]
24. Eukaryotic initiation factors (eIF) 2alpha and 4E expression, localization, and phosphorylation in brain tumors.
    J Histochem Cytochem, 57(5): 503-12. [Abstract] [Full-text]
25. Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors.
    Int J Cancer, 124(12): 2872-9. [Abstract] [Full-text]
26. Characterization of resistance to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patients.
    Eur J Endocrinol, 160(5): 747-52. [Abstract] [Full-text]
27. Redox dependence and compartmentation of [13C]pyruvate in the brain of deuterated rats bearing implanted C6 gliomas.
    J Neurochem, 109: 237-45. [Abstract] [Full-text]
28. CNS metastasis from malignant uveal melanoma: a clinical and histopathological characterisation.
    Br J Ophthalmol, 93(5): 641-4. [Abstract] [Full-text]
29. Autophagy: a strategy for malignant gliomas' resistance to therapy.
    Med Hypotheses, 73(1): 45-7. [Abstract] [Full-text]
30. Repeatability of quantitative parameters derived from diffusion tensor imaging in patients with glioblastoma multiforme.
    J Magn Reson Imaging, 29(5): 1199-205. [Abstract] [Full-text]
31. A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells.
    Cancer Immunol Immunother, 58(7): 1023-32. [Abstract] [Full-text]
32. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
    Radiology, 251(2): 467-75. [Abstract] [Full-text]
33. Chemotherapy with cisplatin and vincristine for optic pathway/hypothalamic astrocytoma in young children.
    Jpn J Clin Oncol, 39(5): 277-83. [Abstract] [Full-text]

© 2004-2010 Brain Tumors Research Today. All Rights Reserved.